Related references
Note: Only part of the references are listed.Temporal Trends in Medication Use and Outcomes in Atrial Fibrillation
Louise Pilote et al.
CANADIAN JOURNAL OF CARDIOLOGY (2013)
Rates of hemorrhage during warfarin therapy for atrial fibrillation
Tara Gomes et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a Real-World Population With Atrial Fibrillation Receiving Anticoagulant Therapy
Vanessa Roldan et al.
CHEST (2013)
Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation Validation of the R2CHADS2 Index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) Study Cohorts
Jonathan P. Piccini et al.
CIRCULATION (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Scores to Predict Major Bleeding Risk During Oral Anticoagulation Therapy: A Prospective Validation Study
Jacques Donze et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation A Report From the Swedish Atrial Fibrillation Cohort Study
Leif Friberg et al.
CIRCULATION (2012)
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
Leif Friberg et al.
EUROPEAN HEART JOURNAL (2012)
Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation
Stavros Apostolakis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Validating a case definition for chronic kidney disease using administrative data
Paul E. Ronksley et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
A systematic review of validated methods for identifying atrial fibrillation using administrative data
Paul N. Jensen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study
Robby Nieuwlaat et al.
THROMBOSIS RESEARCH (2012)
Patterns of Care and Outcomes Differ for Urban Versus Rural Patients With Newly Diagnosed Heart Failure, Even in a Universal Healthcare System
John-Michael Gamble et al.
CIRCULATION-HEART FAILURE (2011)
Risk stratification schemes, anticoagulation use and outcomes: the risk-treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation
Roopinder K. Sandhu et al.
HEART (2011)
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score
Gregory Y. H. Lip et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
A New Risk Scheme to Predict Warfarin-Associated Hemorrhage The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
Margaret C. Fang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
The effect of place of residence an access to invasive cardiac services following acute myocardial infarction
Ansar Hassan et al.
CANADIAN JOURNAL OF CARDIOLOGY (2009)
Validation of a Case Definition to Define Hypertension Using Administrative Data
Hude Quan et al.
HYPERTENSION (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation A Systematic Review
Yi Wan et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2008)
Health care costs and mortality for Canadian urban and rural patients with diabetes: Population-based trends from 1993-2001
Sheri L. Pohar et al.
CLINICAL THERAPEUTICS (2007)
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
BF Gage et al.
AMERICAN HEART JOURNAL (2006)
Accuracy of coding for possible warfarin complications in hospital discharge abstracts
T. Arnason et al.
THROMBOSIS RESEARCH (2006)
Coding of stroke and stroke risk factors using International Classification of Diseases, revisions 9 and 10
RA Kokotailo et al.
STROKE (2005)
Time trends and geographic disparities in acute complications of diabetes in Ontario, Canada
GL Booth et al.
DIABETES CARE (2005)
Identifying hypertension-related comorbidities from administrative data: What's the optimal approach?
AM Borzecki et al.
AMERICAN JOURNAL OF MEDICAL QUALITY (2004)
Validity of information on comorbidity derived from ICD-9-CCM administrative data
HD Quan et al.
MEDICAL CARE (2002)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Why do patients with atrial fibrillation not receive warfarin?
TJ Bungard et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
